ENA-78/CXCL5, Human

CAT:
804-HY-P7158-01
Size:
2 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
ENA-78/CXCL5, Human - image 1

ENA-78/CXCL5, Human

  • UNSPSC Description:

    CXCL5, also known as neutrophil activating peptide 78 (ENA‐78), is a CXC chemokine containing ELR motif. CXCL5 promotes angiogenesis through interaction with its specific receptor CXCR2. CXCL5 is expressed by many immune cells, such as macrophages, eosinophils, and non-immune cells including mesothelial cells, and fibroblasts.CXCL5/CXCR2 axis not only contributes to the recruitment of neutrophils but also regulates the function of neutrophils in melanoma[1][2]. ENA-78/CXCL5 Protein, Human is produced in E.coil, and consists of 70 amino acids (R45-N114).
  • Type:

    Recombinant Proteins
  • Assay Protocol:

    https://www.medchemexpress.com/cytokines/ena-78-cxcl5-protein-human.html
  • Purity:

    95.00
  • Smiles:

    RELRCVCLQT TQGVHPKMIS NLQVFAIGPQ CSKVEVVASL KNGKEICLDP EAPFLKKVIQ KILDGGNKEN
  • Molecular Weight:

    Approximately 7.7 kDa
  • References & Citations:

    [1]Kawamura M, et al. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Eur J Cancer. 2012 Sep;48(14):2244-51.|[2]Kawamura M, et al. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Eur J Cancer. 2012 Sep;48(14):2244-51.|[3]Wen Zhang, et al. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Commun (Lond). 2020 Mar;40(2-3):69-80.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    Stored at -20°C for 2 years